Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 4 of 4 descriptions
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sublingual tizanidine 12 mg | [1] Tizanidine Tizanidine | [1] Tizanidine
Tizanidine
💬1. Sublingual tizanidine 12 mg
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬1. Sublingual tizanidine 12 mg
| ||||||||
| 2 | Tizanidine | [1] Tizanidine Tizanidine | [1] Tizanidine
Tizanidine
💬2. Tizanidine
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬2. Tizanidine
| ||||||||
| 3 | Tizanidine (sublingual or oral) | [1] Tizanidine Tizanidine | [1] Tizanidine
Tizanidine
💬3. Tizanidine (sublingual or oral)
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬3. Tizanidine (sublingual or oral)
| ||||||||
| 4 | Tizanidine hydrochloride capsule | [1] Tizanidine Tizanidine | [1] Tizanidine
Tizanidine
💬4. Tizanidine hydrochloride capsule
| [3] ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 13 13 💬4. Tizanidine hydrochloride capsule
|